7P4E image
Entry Detail
PDB ID:
7P4E
Title:
Crystal structure of PPARgamma in complex with compound FL217
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2021-07-11
Release Date:
2022-07-06
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.23
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Peroxisome proliferator-activated receptor gamma
Chain IDs:A
Chain Length:277
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor gamma Agonists/Soluble Epoxide Hydrolase Inhibitors.
J.Med.Chem. 64 17259 17276 (2021)
PMID: 34818007 DOI: 10.1021/acs.jmedchem.1c01331

Abstact

Polypharmaceutical regimens often impair treatment of patients with metabolic syndrome (MetS), a complex disease cluster, including obesity, hypertension, heart disease, and type II diabetes. Simultaneous targeting of soluble epoxide hydrolase (sEH) and peroxisome proliferator-activated receptor γ (PPARγ) synergistically counteracted MetS in various in vivo models, and dual sEH inhibitors/PPARγ agonists hold great potential to reduce the problems associated with polypharmacy in the context of MetS. However, full activation of PPARγ leads to fluid retention associated with edema and weight gain, while partial PPARγ agonists do not have these drawbacks. In this study, we designed a dual partial PPARγ agonist/sEH inhibitor using a structure-guided approach. Exhaustive structure-activity relationship studies lead to the successful optimization of the designed lead. Crystal structures of one representative compound with both targets revealed potential points for optimization. The optimized compounds exhibited favorable metabolic stability, toxicity, selectivity, and desirable activity in adipocytes and macrophages.

Legend

Protein

Chemical

Disease

Primary Citation of related structures